An analysis of data from nearly 90,000 women who underwent adnexal surgery over a 3-year period shows that robotically assisted procedures were associated with substantially higher costs and increases in intraoperative complications.
An analysis of data from nearly 90,000 women who underwent adnexal surgery over a 3-year period shows that robotically assisted procedures were associated with substantially higher costs and increases in intraoperative complications. The findings, published in Obstetrics & Gynecology, were from a population-based comparison of laparoscopic and robotically assisted procedures.
Love all things tech? Check out our special October issue!
Using a nationwide database, the researchers identified 87,514 women who had undergone adnexal surgery from 2009 to 2012. During that period, they found, use of robotic-assisted oophorectomy increased from 3.5% to 15% and robotically assisted cystectomy from 2.4% to 12.9%.
For robotically assisted versus laparoscopic oophorectomy, the overall complication rates were 7.1% and 6.0%, respectively (odds ratio [OR] 1.20, 95% CI 1.00-1.45, P=.052). The rate of intraoperative complications was higher when oophorectomy was robotically assisted (3.4% versus 2.1%, OR 1.60, 95% CI 1.21-2.13).
Looking at robotically assisted versus laparoscopic cystectomy, the authors found overall complication rates of 3.7% and 2.7%, respectively. The intraoperative complication rate was higher for the robotically assisted procedures (2.0% versus 0.9%, OR 2.40, 95% CI 1.31-4.38).
Comparing costs of robotic versus laparoscopic procedures, total costs for oophorectomy were $2,504 higher (95% CI $2,356-$2.652) and for cystectomy were $3,310 higher (95% CI $3,082-$3,581) with the robot.
During a period when use of robotically assisted adnexal surgery increased rapidly, the authors concluded, the technology was associated with substantially higher costs and a small but statistically significant increase in intraoperative complications compared with laparoscopy.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More